{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:49:49Z","timestamp":1754110189008,"version":"3.40.5"},"reference-count":86,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2017,4,3]]},"DOI":"10.1080\/17512433.2017.1283983","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T00:28:50Z","timestamp":1484699330000},"page":"391-400","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Biosimilars in Inflammatory Bowel Disease - Accumulating Clinical Evidence"],"prefix":"10.1080","volume":"10","author":[{"given":"Sean","family":"McConachie","sequence":"first","affiliation":[{"name":"Department of Pharmacy,  Harper University Hospital , Detroit, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7045-6690","authenticated-orcid":false,"given":"Sheila M.","family":"Wilhelm","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences,  Wayne State University , Detroit, MI, USA"},{"name":"Harper University Hospital , Detroit, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8729-7710","authenticated-orcid":false,"given":"Pramodini B.","family":"Kale-Pradhan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences,  Wayne State University , Detroit, MI, USA"},{"name":"St. John Hospital and Medical Center , Detroit, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,1,29]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2014.09.006"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.02.023"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.01.002"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2016.14.1.15"},{"volume-title":"Guidance for Industry","year":"2015","author":"Scientific Consideration in Demonstrating Biosimilarity to a Reference Product","key":"cit0005"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.04.005"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2015.03.011"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.01.001"},{"key":"cit0009","unstructured":"US Food and Drug Administration . Guidance for Industry: reference Product Exclusivity for Biological Products Filed Under Section 351(a) of the PHS Act. Maryland: FDA; 2014. p. 11."},{"volume-title":"Guidance for industry: formal meetings between the fda and biosimilar biological products sponsors or applicants","year":"2015","author":"US Food and Drug Administration","key":"cit0010"},{"volume-title":"Guidance for industry: clinical pharmacology data to support a demonstration of biosimilarity to a reference product","year":"2014","author":"US Food and Drug Administration","key":"cit0011"},{"volume-title":"Guidance for industry: quality considerations in demonstrating biosimilarity of a therapeutic protein product to a reference product","year":"2015","author":"US Food and Drug Administration","key":"cit0012"},{"volume-title":"Guideline on similar biological medicinal products","year":"2005","author":"European Medicines Agency","key":"cit0013"},{"volume-title":"Guidelines on evaluation of similar biolotherapeutic products (SBPs)","year":"2009","author":"World Health Organization","key":"cit0014"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.04.002"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00381-2"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.02.007"},{"key":"cit0018","unstructured":"Office of Regulatory Affairs, Biologics and Genetic Therapies Directorate  . Inflectra: summary of basis decision; 2015. http:\/\/www.hc-sc.gc.ca\/[accessed 10\/24\/2016]. Available from: http:\/\/www.hc-sc.gc.ca\/dhp-mps\/prodpharma\/sbd-smd\/drug-med\/sbd_smd_2014_inflectra_159493-eng.php."},{"volume-title":"State laws and legislation related to biologic medications and substitution of biosimilars","year":"2014","author":"Legislatures, N.C.o.S","key":"cit0019"},{"key":"cit0020","unstructured":"Ault A   FDA adviser\u2019s back infliximab biosimilar, CT-P13. 2016 [Cited 2016 May 1]; Available from: http:\/\/www.medscape.com\/viewarticle\/858749?src=WNL_infoc_160228_MSCPEDIT&uac=65099CG&impID=1004269&faf=1."},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12432"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-015-0233-1"},{"issue":"6","key":"cit0023","first-page":"S129","volume":"33","author":"Hatemi I","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.727"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.168"},{"volume-title":"Remicade\u00ae [package insert]","year":"2015","key":"cit0026"},{"volume-title":"Humira\u00ae [package insert]","year":"2002","key":"cit0027"},{"volume-title":"Cimzia\u00ae [package insert]","year":"2008","key":"cit0028"},{"volume-title":"Simponi\u00ae [package insert]","year":"2009","key":"cit0029"},{"volume-title":"Entyvio\u00ae [package insert]","year":"2014","key":"cit0030"},{"volume-title":"Tysabri\u00ae [package insert]","year":"2004","key":"cit0031"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X14558193"},{"volume-title":"FDA approves Inflectra, a biosimilar to Remicade","year":"2016","author":"Pahon E","key":"cit0033"},{"key":"cit0034","unstructured":"FDA approves Amjevita, a biosimilar to Humira. FDA News Release  2016 [cited 2016 Sep 24]; Available from: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm522243.htm."},{"issue":"1","key":"cit0035","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1586\/1744666X.2015.1090311","volume":"11","author":"Park W","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203091"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203090"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.06.002"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.374"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000212"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-009-0718-4"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1177\/0091270008316886"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.28674"},{"issue":"5","key":"cit0044","first-page":"S","volume":"138","author":"Van Moerkercke W","year":"2010","journal-title":"Gastroenterology"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.06.025"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307883"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(13)60128-6"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.08.035"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.024"},{"issue":"2","key":"cit0050","volume":"106","author":"D\u2019Haens GR","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2015.09.005"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.04997.x"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21839"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2015.1091307"},{"key":"cit0055","doi-asserted-by":"crossref","unstructured":"Ben-Horin S , \n                     Yavzori M , \n                     Benhar I , et al. Cross-immunogenicity: antibodies to infliximab in Remicade-treated patients with IBD similarly recognise the biosimilar Remsima. \u00a0Gut. 2016;65(7):1132\u20131138.","DOI":"10.1136\/gutjnl-2015-309290"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-0930-4"},{"volume-title":"CB Leiden","year":"2009","author":"Infliximab(R) [package insert]","key":"cit0057"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208783"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-0981-6"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.05.023"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3392-z"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X16636764"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2015.1064893"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12997"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2015.1091309"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2015.1091308"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv220"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw087"},{"key":"cit0069","first-page":"S10","volume":"68","author":"Goll GL","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(16)30424-3"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050516"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08512-4"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw085"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2015.1054422"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.03.011"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.06.007"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2014.07.019"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw090"},{"key":"cit0079","unstructured":"FDA approves Erelzi, a biosimilar to Enbrel  . FDA news release 2016; Available from: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm518639.htm."},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208914"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-016-0184-3"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-016-0185-2"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13039"},{"issue":"10","key":"cit0084","volume":"67","author":"Matsumoto AK","year":"2015","journal-title":"Arthritis Rheumatol"},{"volume-title":"FDA briefing document: ABP 501, a proposed biosimilar to Humira (adalimumab)","year":"2016","author":"US Food and Drug Administration","key":"cit0085"},{"key":"cit0086","unstructured":"Rockoff JD  . AbbVie Files Patent Suit Over Amgen's Copy of Humira. The Wall Street Journal. Dow Jones & Company, 2016 Aug 5. Web: 2016 Nov 11."}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2017.1283983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T12:36:34Z","timestamp":1605616594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2017.1283983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,29]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4,3]]}},"alternative-id":["10.1080\/17512433.2017.1283983"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2017.1283983","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"type":"print","value":"1751-2433"},{"type":"electronic","value":"1751-2441"}],"subject":[],"published":{"date-parts":[[2017,1,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-11-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-01-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-01-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}